Affiliation:
1. North-Ossetian State Medical Academy
2. Kuban State Medical Institute
Abstract
Objective: to study the causes of pancreatitis. Materials and methods: a clinical case of acute pancreatitis during the treatment of ulcerative colitis with 5-aminosalicylic acid-containing drugs. Methods: clinical, laboratory and instrumental (biochemical blood analysis, standard coprological examination, Ultrasound examination of the abdominal cavity, Esophagogastroduodenoscopy). Results: based on the data of the clinic, laboratory and instrumental studies, a diagnosis was made: drug-induced pancreatitis associated with mesalazine intake. Ulcerative colitis, total form, high degree of activity. Duodenal ulcer disease associated with Helicobacter pylori, unstable remission. Erosive bulbitis. The indicated therapy with polyenzyme drugs, proton pump inhibitors, antispasmodics, and glucocorticosteroids resulted in the resolution of clinical manifestations and the normalization of altered laboratory parameters. Conclusions: the use of 5-aminosalicylic acid preparations for the treatment of ulcerative colitis may be associated with the development of pancreatitis, which must be taken into account in clinical practice.
Publisher
Rostov State Medical University
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference15 articles.
1. Glavnov P.V., Lebedeva N.N., Kashchenko V.A., Varzin S.A. Ulcer colitis and Crohn’s disease. Current state of a problem ofan etiology, early diagnostics and treatment (review of literature). Bulletin of St. Petersburg State University. 2015;11(4):48-72. (In Russ.). eLIBRARY ID: 25805082
2. Ransford R.A., Langman M.J. Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines. // Gut. - 2002. - V.51 (4). - P. 536–539. DOI: 10.1136/gut.51.4.536
3. Kubyshkin V.A., Zatevakhin I.I., Bagnenko S.F., et.al. eds. Klinicheskie rekomendatsii. Ostryi pankreatit. Moscow: Ministerstvo zdravookhraneniya Rossiiskoi Federatsii; 2015. (In Russ.)
4. Sutherland L., May G., Shaffer E. Sulfasalazine revisited: a meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis.// Ann intern Med. - 1993.-V.-118(7). - Р.540-549. DOI: 10.7326/0003-4819-118-7-199304010-00009
5. Feagan B.G., Macdonald J.K. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. // Cochrane Database Syst Rev. – 2012. – V.10 CD000544. DOI: 10.1002/14651858.CD000544.pub3.